Bristol-Myers Squibb - Company & Market Research Reports

Home /
Companies /
Bristol-Myers Squibb

Bristol-Myers Squibb is a pharmaceutical company that develops products for various diseases, such as oncology, virology, cardiovascular diseases, serious mental illness, and immunoscience. The company has delivered 12 new medicines to patients in the past 7 years. It also provides products for Alzheimer's disease, atherosclerosis/thrombosis, hepatitis, HIV/AIDS, solid organ transplant rejection, and a wide variety of other diseases and disorders. Bristol-Myers Squibb was founded in 1990 and is based in Uxbridge, United Kingdom.

REFINE BY

KEYWORD

CATEGORIES

Oncology Drugs 476
Immune Disorders Drugs 202
Drug Discovery 170
Cardiovascular Drugs 157
Infectious Diseases Drugs 135
Biopharmaceuticals 130
Clinical Trials 125
Endocrine and Metabolic Disorders Drugs 110
Central Nervous System Drugs 100
Pharmaceuticals 95
Musculoskeletal Disorders Drugs 94
Leukemia Drugs 85
Hematological Drugs 84
Liver and Kidney Disorders Drugs 79
Lymphoma Drugs 62
Diabetes Drugs 55
Dermatological Drugs 55
Skin Cancer Drugs 51
Brain Cancer Drugs 45
Respiratory Drugs 44
Gastrointestinal Drugs 42
Mental Disorders Drugs 41
Lung Cancer Drugs 39
Drug Delivery 37
Pharmaceutical Intermediates 36
Immunosuppressive Drugs 34
Pharmaceutical Manufacturing 32
Infusions and Injectables 30
Liver Cancer Drugs 28
Analgesics 25
Drugs by Therapeutic Area 24
Bladder Cancer Drugs 24
Antibiotics 23
Kidney Cancer Drugs 22
Colon Cancer Drugs 20
HIV/AIDS Drugs 20
Schizophrenia Drugs 19
Prostate Cancer Drugs 18
Pancreatic Cancer Drugs 18
Urological Disorders Drugs 17
Sexual and Reproductive Health Drugs 15
Breast Cancer Drugs 14
Ovarian Cancer Drugs 14
Cervical Cancer Drugs 14
Cancer Vaccines 13
Thyroid Cancer Drugs 12
Psoriasis Drugs 12
Generic Drugs 10
Biosimilars and Biosuperiors 10
Over the Counter (OTC) Drugs 9
Vaccines 9
Transdermal and Transmucosal Drug Delivery 8
Anti-Obesity Drugs 8
Alzheimer's Disease Drugs 8
Optical Disorders Drugs 7
Uterine Cancer Drugs 6
Company Reports 5
Anxiety Drugs 4
Pharmacoeconomics 3
Cough and Cold Drugs 3
Vitamins and Dietary Supplements 3
Addiction Disorders Drugs 2
Animal Pharmaceuticals 2
Asthma Drugs 2
Inhalers and Nebulisers 1
Anesthetic Drugs 1
Allergy Drugs 1
Bronchitis Drugs 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



274 reviews

2,452 Results (Page 41 of 123)
- Relevance
  Sort by

Cervical Cancer Treatment - Global Strategic Business Report

 Report
April 2025
93 Pages
Global

From

€5317EUR$5,850USD£4,553GBP

Osteoporosis Market Report and Forecast 2024-2032

 Report
February 2024
180 Pages
Global

From

€4517EUR$4,969USD£3,867GBP

Europe Pharmaceutical Market Size, Share & Trends Analysis Report By Product (Branded, Generic), By Type (Prescription, OTC), By Therapeutic Category, By Region, and Segment Forecasts, 2021-2028

 Report
October 2021
190 Pages
Europe

From

€5408EUR$5,950USD£4,631GBP

Chemotherapy Induced Peripheral Neuropathy Treatment Market Report 2025

 Report
February 2025
200 Pages
Global

From

€4081EUR$4,490USD£3,495GBP

Cutaneous Lupus Erythematosus - Pipeline Insight, 2024

 Clinical Trials
April 2024
80 Pages
Global

From

€1363EUR$1,500USD£1,167GBP

NEED HELP FINDING THE RIGHT PRODUCT? Craig will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

Contract Research and Manufacturing Services (CRAMS) Market Report 2025

 Report
March 2025
200 Pages
Global

From

€4081EUR$4,490USD£3,495GBP

Psoriatic Arthritis Therapeutics Market Report and Forecast 2023-2031

 Report
April 2023
160 Pages
Global

From

€4498EUR$4,949USD£3,852GBP

Systemic Sclerosis - Pipeline Insight, 2024

 Clinical Trials
April 2024
80 Pages
Global

From

€2272EUR$2,500USD£1,946GBP

Polycythemia Vera Drug Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type

 Report
September 2024
99 Pages
Global

From

€3500EUR$4,125USD£3,102GBP

Psoriatic Arthritis Treatment Market Report and Forecast 2023-2031

 Report
May 2023
160 Pages
Global

From

€4498EUR$4,949USD£3,852GBP

Neuropathic Pain Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

 Report
December 2023
182 Pages
Global

€4540EUR$4,995USD£3,888GBP

Factor IX A Inhibitor - Pipeline Insight, 2024

 Clinical Trials
January 2024
60 Pages
Global

From

€1136EUR$1,250USD£973GBP

U.S. And Europe Pharmaceutical Manufacturing Market Size, Share & Trends Analysis Report By Product Type, By Type, By Drug Development Type, By Formulation, By Routes of Administration, And Segment Forecasts, 2023 - 2030

 Report
January 2023
150 Pages
United States, Europe United States, Europe

From

€5408EUR$5,950USD£4,631GBP

Africa Pharmaceuticals Market - Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (Africa)

 Report
December 2023
261 Pages
Africa

€4540EUR$4,995USD£3,888GBP

Germany Drug Delivery Market - Forecast from 2021 To 2026

 Report
January 2022
75 Pages
Germany

From

€2045EUR$2,250USD£1,751GBP

Saxagliptin Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

 Report
April 2023
72 Pages
Global

From

€3500EUR$4,125USD£3,102GBP

Thrombocytopenia Management Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type

 Report
September 2024
96 Pages
Global

From

€3500EUR$4,125USD£3,102GBP

Schizophrenia Therapeutics Global Market Insights 2022, Analysis and Forecast to 2027, by Manufacturers, Regions, Technology, Application, Product Type

 Report
July 2022
85 Pages
Global

From

€3500EUR$4,125USD£3,102GBP

Sickle Cell Disease Drug Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application

 Report
August 2024
96 Pages
Global

From

€3500EUR$4,125USD£3,102GBP

Recurrent Glioblastoma Multiform Treatment Global Market Insights 2022, Analysis and Forecast to 2027, by Manufacturers, Regions, Technology, Application, Product Type

 Report
August 2022
Global

From

€3500EUR$4,125USD£3,102GBP

2,452 Results (Page 41 of 123)
- 1
- 39
- 40
- 41
- 42
- 43

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.